{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Mustang Bio, Inc."},"Symbol":{"label":"Symbol","value":"MBIO"},"Address":{"label":"Address","value":"377 PLANTATION STREET, WORCESTER, Massachusetts, 01605, United States"},"Phone":{"label":"Phone","value":"+1 781 652-4500"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies and CAR T therapies for solid tumors."},"CompanyUrl":{"label":"Company Url","value":"https://www.mustangbio.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Bruce Dezube","title":"Chief Medical Officer"},{"name":"Greg Furrow","title":"Chief Technology Officer, SVP & Head-Quality"},{"name":"James Edinger","title":"Chief Scientific Officer"},{"name":"Kerry Biron","title":"Vice President & Head-Clinical Operations"},{"name":"Manuel Litchman","title":"President, CEO, CFO & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}